PlainPharmaWatch

CMS Open Payments · Tool

MicroPort Orthopedics Inc vs Visby Medical, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Visby Medical, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 2,338, versus 1,182 for the other company. Its single largest recorded recipient represents 27.2% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

MicroPort Orthopedics Inc
HHI 1,182 · top recipient 24.7%
Ranked #956 of 1,838 companies by HHI
Visby Medical, Inc.
HHI 2,338 · top recipient 27.2%
Ranked #685 of 1,838 companies by HHI

Payment Overview

Total Payments
$3.0M
% of Industry
0.0%
Transactions
1,050
Avg per Transaction
$2.9K
Recipients
1,014
Avg per Recipient
$3.0K
Payment Types
6
Top Payment Type
Royalty or License
Total Payments
$3.0M
% of Industry
0.0%
Transactions
187
Avg per Transaction
$16.2K
Recipients
30
Avg per Recipient
$101.2K
Payment Types
2
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

MicroPort Orthopedics Inc vs Visby Medical, Inc. - total reported payments in CMS Open Payments PY2024

Visby Medical, Inc.$3.0MMicroPort Orthopedics Inc$3.0M

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

MicroPort Orthopedics Inc

Royalty or License $2.2M

78.0%

Travel and Lodging $210.0K

7.6%

Compensation for Services Other Than Consulting $178.8K

6.5%

Consulting Fee $154.6K

5.6%

Food and Beverage $33.1K

1.2%

Space Rental or Facility Fees $31.9K

1.2%

Visby Medical, Inc.

Consulting Fee $73.2K

99.7%

Food and Beverage $230.74

0.3%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

MicroPort Orthopedics Inc

  1. 1

    STEPHEN MURPHY

    $682,091.72 · 5 txns

  2. 2

    JAMES CHOW

    $531,455.65 · 7 txns

  3. 3

    ROBERT STEENSEN

    $275,168.75 · 23 txns

  4. 4

    STEPHEN INCAVO

    $131,756.46 · 4 txns

  5. 5

    DAVID BACKSTEIN

    $105,319.59 · 59 txns

Visby Medical, Inc.

  1. 1

    RICHARD J WHITLEY

    $20,000.00 · 4 txns

  2. 2

    ANGELA M CALIENDO

    $20,000.00 · 4 txns

  3. 3

    EDWARD W HOOK

    $15,000.00 · 4 txns

  4. 4

    DAVID RELMAN

    $15,000.00 · 4 txns

  5. 5

    JEFFREY D KLAUSNER

    $3,187.50 · 2 txns

Summary Comparison

Metric MicroPort Orthopedics Inc Visby Medical, Inc.
Total Payments $3.0M $3.0M
% of Industry Total 0.0% 0.0%
Transaction Count 1,050 187
Avg per Transaction $2.9K $16.2K
Recipient Count 1,014 30
Avg per Recipient $3.0K $101.2K
Payment Type Count 6 2
Top Payment Type Royalty or License Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.